Urinary Biomarkers and Patient Outcome in Chronic Kidney Disease and Atherosclerotic Heart Disease: The value of IgM-uria and IgG-uria
Author
Summary, in English
In study I, 139 patients with type-1 diabetes, and in study II, 106 patients with type-2 diabetes, were followed at the diabetes outpatient clinic, for an average of 18 and 5 years, respectively. Type-1 & -2 diabetic patients had about a 3-fold increase in CV and renal mortality (HR = 2.7, p = 0.004, and HR = 3.6, p < 0.001, respectively) if they had an increased urine IgM excretion, even when adjusted to the degree of albuminuria. In study III, 178 consecutive patients who presented with acute chest pain to the emergency department of Lund University Hospital were followed for up to 2 years. Patients with acute coronary syndrome had significantly higher baseline IgM-uria than those with non-specific chest pain. Chest pain patients with IgM-uria at time of presentation had a 3-fold higher risk for the occurrence of subsequent major CV event (HR = 3.3, p = 0.001). In study IV, 189 patients with proteinuric primary glomerulonephritis were followed at the nephrology outpatient clinic for an average of 8 years. Patients with an increased urine IgG excretion had an increased risk for end-stage kidney disease (ESKD), even when adjusted for the degree of albuminuria and kidney function (HR = 5.9, p = 0.001).
In conclusion, IgM-uria could be a useful biomarker for kidney and cardiovascular risk assessment of patients with diabetes and atherosclerotic heart disease. IgM- uria could imply an extensive atherosclerotic vascular disease. IgG-uria is helpful in identifying patients with glomerulonephritis at increased risk for disease progression to ESKD.
Department/s
Publishing year
2014
Language
English
Publication/Series
Lund University Faculty of Medicine Doctoral Dissertation Series
Volume
2014:105
Full text
Document type
Dissertation
Publisher
Department of Nephrology, Lund University
Topic
- Urology and Nephrology
Keywords
- Proteinuria
- Albuminuria
- urine IgM
- urine IgG
- glomerulonephritis
- chronic kidney disease
- atherosclerosis
- cardiovascular disease
- diabetic kidney disease.
Status
Published
Supervisor
- Omran Bakoush
- Ulf Ekelund
- Bengt Rippe
- Ole Torffvit
ISBN/ISSN/Other
- ISSN: 1652-8220
- ISBN: 978-91-7619-034-0
Defence date
27 September 2014
Defence time
10:00
Defence place
Segerfalksalen, BMC, Sölvegatan 17, Lund
Opponent
- Bengt Lindholm (Dr.)